NEW YORK, Dec. 13 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company will host a conference call on December 18 at 8:00 am (ET) to review data presented at the American Society of Hematology (ASH) 48th Annual Meeting and Exposition, held from December 9-12 in Atlanta, FL. Company executives will provide an overview of data presented at the meeting for several oncology and cardiovascular compounds and address questions from investors and analysts.
Investors and the general public are invited to listen to a live webcast of the call at http://www.bms.com/ir or by dialing 913-981-5543. A replay of the call will be available beginning at 2:00 p.m. (ET) on December 18 through 8:00 p.m. (ET) on December 31. The replay can be accessed at http://www.bms.com/ir or by dialing 402-280-9013 (access code 9358124).
Bristol-Myers Squibb is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life.
Bristol-Myers Squibb CompanyCONTACT: Media: Tony Plohoros, Communications, +1-212-546-4379,tony.plohoros@bms.com, or Jeff Macdonald, Communications, +1-212-546-4824,jeffrey.macdonald@bms.com, or Investors: John Elicker, Investor Relations,+1-212-546-3775, john.elicker@bms.com, or Blaine Davis, Investor Relations,+1-212-546-4631, blaine.davis@bms.com, all of Bristol-Myers Squibb Company
